2024 is the Year the ASU Biodesign Institute Celebrates 20 Years of Nature-Inspired Innovation

Biodesign scientists have created a therapy against the Ebola virus, discovered an early diagnostic for breast cancer and provided data that brought potentially harmful chemicals in personal-care products to light.

These are just a handful of ways our research is leading to discoveries and inventions that answer today’s challenges. As the premier scientific research institute in the nation’s fastest-growing research university, Biodesign’s impact is accelerating. We invite you to explore highlights of our accomplishments and join us in designing a better future.Continue reading

C-Path’s TRxA Announces its 2024 Global Request for Proposals from Academic Investigators Working to Advance Drug Development Projects

NEW FUNDING OPPORTUNITY!

TUCSON, Ariz, January 22, 2024 – Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) today announced its 2024 global Request for Proposals for its Breakthrough Research and Innovation in Drug Development Grants, also known as BRIDGe. Continue reading

Bill Proposing an Appropriation into the Arizona Health Innovation Trust Fund Receives Unanimous Support in the Senate Health and Human Services Committee

SB1019: appropriation; health innovation trust fund received its first hearing in Arizona’s Senate Health and Human Services Committee on January 16, 2024.  As currently written, SB1019 appropriates $5M to the Arizona Health Innovation Trust Fund, and declares that it is the Legislature’s intent that the Fund, consisting of monies appropriated by the Legislature, gifts or grants donated or given to the Fund and earnings from the Fund, steadily grow to ultimately maintain a permanent endowment balance of at least $200 million. 

SB1019 received a unanimous do pass recommendation.  It now is eligible for consideration by the Senate Appropriations Committee.Continue reading